Back
Jumia Technologies AG Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
33
JMIA
Jumia Technologies AG
Last Price:
$4.03
Seasonality Move:
-12.58%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$105.29
Seasonality Move:
1.75%
Sell
33
Jumia Technologies AG (JMIA)
is a Sell
Is Jumia Technologies AG a Buy, Sell or Hold?
-
The current Jumia Technologies AG [JMIA] share price is $4.15. The Score for JMIA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
JMIA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JMIA Stock Price Chart
What is Jumia Technologies AG's stock price today?
-
The Jumia Technologies AG share price today is $4.15The current trend is relatively stagnant and JMIA is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $107.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
JMIA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 54.24 | Buy |
| Chaikin Money Flow: | -663989 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.79 - 4.09) | Buy |
| Bollinger Bands (100): | (3.79 - 4.91) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.94 | Sell |
| Relative Strength Index (14 RSI): | 33.84 | Sell |
| Chaikin Money Flow: | -502758 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.52 - 119.16) | Sell |
| Bollinger Bands (100): | (114.38 - 127.78) | Sell |
JMIA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.05 | Buy |
| 20-day SMA: | 3.98 | Buy |
| 50-day SMA: | 4.07 | Buy |
| 200-day SMA: | 5.85 | Sell |
| 8-day EMA: | 4.06 | Buy |
| 20-day EMA: | 4.01 | Buy |
| 50-day EMA: | 4.1 | Buy |
| 200-day EMA: | 4.91 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.57 | Sell |
| 20-day SMA: | 114.25 | Sell |
| 50-day SMA: | 119.8 | Sell |
| 200-day SMA: | 128.55 | Sell |
| 8-day EMA: | 110.88 | Sell |
| 20-day EMA: | 113.91 | Sell |
| 50-day EMA: | 117.81 | Sell |
| 200-day EMA: | 123.39 | Sell |
Jumia Technologies AG Earnings Growth & JMIA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Jumia Technologies AG Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||